Consilium Scientific received 2-year grant funding from Arnold Ventures to develop the Evimeter for the evaluation of novel non-pharmaceutical products.

This project focuses on a specific policy challenge. The 21^st Century Cures Act of 2016 required Medicare Administrative Contractors (MACs) to justify non-coverage local determinations for products that have limited or no evidence generalizable to the Medicare population at the time of authorization by the U.S. Food and Drug Administration (FDA).

To address this challenge, Consilium Scientific will research the evidence grading of medical technologies represented by Category III codes (innovative medical devices, diagnostics, imaging, digital products). Specifically, using the proprietary Evimeter tool we will determine the quality and quantity of evidence and transparency underpinning healthcare technologies receiving Category III coding. We will compare them to similar technologies which are already on the market under Category I codes.

Leeza Osipenko, PhD

Ekaterina Cleary, PhD

Jack Lewis, MSc

Andrea Caputo Svensson, PhD

Scott Lewis, MSc

Dr. Julie Eggington

Dr. Louis Jacques

Dr. Marta Villarraga